Skip to content

PHARMACIE C. BERNARD: what changed

BE 0453.532.111NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€36,372
2024 · €39,970-€3,598
Equity
€415,073
2024 · €566,010-€150,936
Cash
€144,126
2024 · €175,808-€31,682
Balance sheet total
€1.3m
2024 · €1.4m-€148,259

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€80,168

    down €80,168 (-8.7%), from €923,681 to €843,513

  • Receivables within one year -€46,120

    down €46,120 (-29.1%), from €158,617 to €112,497

    of which Trade receivables: -€43,636

  • Cash -€31,682

    down €31,682 (-18.0%), from €175,808 to €144,126

    mainly Contributions, distributions and other (-€187,309) and Trade debts (-€98,936)

  • Stocks and contracts +€25,523

    up €25,523 (+16.8%), from €152,135 to €177,659

  • Deferred charges and accrued income -€15,812

    down €15,812 (-98.5%), from €16,055 to €242

Equity and liabilities
  • Other debts +€174,164

    up €174,164 (+224%), from €77,835 to €251,999

  • Reserves -€150,936

    down €150,936 (-27.6%), from €547,410 to €396,473

    of which Distributable reserves: -€150,936

  • Trade debts -€98,936

    down €98,936 (-51.3%), from €192,750 to €93,814

  • Debts after one year -€68,277

    down €68,277 (-14.7%), from €463,793 to €395,516

Income statement
  • Gross operating margin +€57,214

    up €57,214 (+19.0%), from €300,861 to €358,075

  • Depreciation +€23,494

    up €23,494 (+35.4%), from €66,342 to €89,836

  • Staff costs +€19,437

    up €19,437 (+12.2%), from €159,125 to €178,562

  • Financial charges +€9,831

    up €9,831 (+46.9%), from €20,942 to €30,773

  • Taxes +€7,652

    up €7,652 (+102%), from €7,511 to €15,164

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €39,970
Gross operating margin +€57,214
Staff costs -€19,437
Depreciation -€23,494
Other operating charges -€195
Financial income -€203
Financial charges -€9,831
Taxes -€7,652
Result 2025 €36,372
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€255,775
Investment -€9,668
Financing -€277,789
Cash 2024 €175,808
Net result for the year +€36,372
Depreciation +€89,836
Stocks and contracts -€25,523
Receivables within one year +€46,120
Deferred charges and accrued income +€15,812
Trade debts -€98,936
Tax, wage and social debts +€14,252
Other debts +€174,164
Accrued charges and deferred income +€3,677
Investment in fixed assets (net) -€9,668
Debts after one year -€68,277
Current portion of long-term debt -€14,025
Short-term financial debts -€8,177
Contributions, distributions and other -€187,309
Cash 2025 €144,126
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,426,296 €1,278,037 -€148,259 -10.4%
Fixed assets 21/28 €923,681 €843,513 -€80,168 -8.7%
Tangible fixed assets 22/27 €923,681 €843,513 -€80,168 -8.7%
Land and buildings 22 €310,806 €288,275 -€22,530 -7.2%
Plant, machinery and equipment 23 €464,020 €425,933 -€38,086 -8.2%
Furniture and vehicles 24 €41,925 €23,036 -€18,889 -45.1%
Other tangible fixed assets 26 €106,930 €106,268 -€662 -0.6%
Current assets 29/58 €502,615 €434,524 -€68,091 -13.5%
Stocks and contracts in progress 3 €152,135 €177,659 +€25,523 +16.8%
Stocks 30/36 €152,135 €177,659 +€25,523 +16.8%
Amounts receivable within one year 40/41 €158,617 €112,497 -€46,120 -29.1%
Trade receivables 40 €154,122 €110,486 -€43,636 -28.3%
Other amounts receivable 41 €4,495 €2,011 -€2,484 -55.3%
Cash at bank and in hand 54/58 €175,808 €144,126 -€31,682 -18.0%
Deferred charges and accrued income 490/1 €16,055 €242 -€15,812 -98.5%
Total equity and liabilities 10/49 €1,426,296 €1,278,037 -€148,259 -10.4%
Equity 10/15 €566,010 €415,073 -€150,936 -26.7%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €547,410 €396,473 -€150,936 -27.6%
Non-distributable reserves 130/1 €0 - =
Reserves not available under the articles 1311 €0 - =
Distributable reserves 133 €547,410 €396,473 -€150,936 -27.6%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €860,286 €862,964 +€2,678 +0.3%
Amounts payable after more than one year 17 €463,793 €395,516 -€68,277 -14.7%
Financial debts 170/4 €463,793 €395,516 -€68,277 -14.7%
Amounts payable within one year 42/48 €389,625 €456,904 +€67,278 +17.3%
Current portion of amounts payable after more than one year 42 €82,302 €68,277 -€14,025 -17.0%
Financial debts 43 €8,177 €0 -€8,177 -100%
Credit institutions 430/8 €8,177 €0 -€8,177 -100%
Trade debts 44 €192,750 €93,814 -€98,936 -51.3%
Suppliers 440/4 €192,750 €93,814 -€98,936 -51.3%
Taxes, remuneration and social security 45 €28,561 €42,813 +€14,252 +49.9%
Taxes 450/3 €1,051 €9,117 +€8,066 +767%
Remuneration and social security 454/9 €27,510 €33,697 +€6,187 +22.5%
Other amounts payable 47/48 €77,835 €251,999 +€174,164 +224%
Accrued charges and deferred income 492/3 €6,868 €10,545 +€3,677 +53.5%
Remuneration, social security and pensions 62 €159,125 €178,562 +€19,437 +12.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €66,342 €89,836 +€23,494 +35.4%
Other operating charges 640/8 €8,675 €8,869 +€195 +2.2%
Gross operating margin 9900 €300,861 €358,075 +€57,214 +19.0%
Operating profit (loss) 9901 €66,719 €80,808 +€14,088 +21.1%
Financial income 75/76B €1,704 €1,501 -€203 -11.9%
Recurring financial income 75 €1,704 €1,501 -€203 -11.9%
Financial charges 65/66B €20,942 €30,773 +€9,831 +46.9%
Recurring financial charges 65 €20,942 €30,773 +€9,831 +46.9%
Profit (loss) for the period before taxes 9903 €47,481 €51,536 +€4,055 +8.5%
Income taxes 67/77 €7,511 €15,164 +€7,652 +102%
Profit (loss) for the period 9904 €39,970 €36,372 -€3,598 -9.0%
Profit (loss) for the period to be appropriated 9905 €39,970 €36,372 -€3,598 -9.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€369,051 to €433,657

Midpoint €395,970 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €415,073
Capitalised earnings €323,029 to €452,240
Indication €369,051 to €433,657

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€415,073
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€415,073

Capitalised earnings

net result for the year (9904)
2025
€36,372
2024
€39,970
2023
€59,328
2022
€70,325
2021
€57,962
Average result
€45,224
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€323,029 / €376,867 / €452,240

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.